These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1175 related items for PubMed ID: 20586932

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure.
    Zhai S, Zhang L, Dang S, Yu Y, Zhao Z, Zhao W, Liu L.
    Viral Immunol; 2011 Aug; 24(4):303-10. PubMed ID: 21721931
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
    Yan Z, Zhou J, Zhang M, Fu X, Wu Y, Wang Y.
    Mol Med Rep; 2014 May; 9(5):2024-30. PubMed ID: 24626572
    [Abstract] [Full Text] [Related]

  • 10. Relations of regulatory T cells with hepatitis markers in chronic hepatitis B virus infection.
    El-Badawy O, Sayed D, Badary MS, Abd-Alrahman ME, El-Feky MA, Thabit AG.
    Hum Immunol; 2012 Apr; 73(4):335-41. PubMed ID: 22342871
    [Abstract] [Full Text] [Related]

  • 11. Circulating CD4+CD25high regulatory T cells and expression of PD-1 and BTLA on CD4+ T cells in patients with chronic hepatitis B virus infection.
    Nan XP, Zhang Y, Yu HT, Li Y, Sun RL, Wang JP, Bai XF.
    Viral Immunol; 2010 Feb; 23(1):63-70. PubMed ID: 20121403
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes.
    Kondo Y, Ueno Y, Kobayashi K, Kakazu E, Shiina M, Inoue J, Tamai K, Wakui Y, Tanaka Y, Ninomiya M, Obara N, Fukushima K, Ishii M, Kobayashi T, Niitsuma H, Kon S, Shimosegawa T.
    J Infect Dis; 2010 Jul 15; 202(2):202-13. PubMed ID: 20533879
    [Abstract] [Full Text] [Related]

  • 13. [Studies about the level of CD4+ CD25+ regulatory T cells and relation between expression of Foxp3 and CD127 in peripheral blood of chronic HBV infection].
    Deng M, Li MH, Liu SA, Liu F, Sang Y, Song SJ, Zang SF, Guan XP, Yao X, Wu XP, Cheng J, Xu DZ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb 15; 24(1):21-3. PubMed ID: 20848841
    [Abstract] [Full Text] [Related]

  • 14. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Feng X, Li B, Ye H, Long D.
    Arch Immunol Ther Exp (Warsz); 2011 Aug 15; 59(4):309-14. PubMed ID: 21633918
    [Abstract] [Full Text] [Related]

  • 15. Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection.
    Peng G, Li S, Wu W, Sun Z, Chen Y, Chen Z.
    Immunology; 2008 Jan 15; 123(1):57-65. PubMed ID: 17764450
    [Abstract] [Full Text] [Related]

  • 16. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
    Huang Y, Wang F, Wang Y, Zhu Z, Gao Y, Ma Z, Xu R, Du Z.
    J Gastroenterol Hepatol; 2014 Apr 15; 29(4):851-9. PubMed ID: 24303990
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 59.